A specialized hepatology referral center is evaluating a novel non-invasive serum biomarker panel to identify advanced hepatic fibrosis in patients with metabolic dysfunction-associated steatohepatitis. The baseline prevalence of advanced fibrosis in this specific clinic population is . The manufacturer's documentation includes a receiver operating characteristic (ROC) curve for the assay.
To align with 2026 consensus guidelines aimed at minimizing the risk of missing patients who require urgent hepatocellular carcinoma screening and intervention, the clinic's quality improvement committee decides to shift the positive diagnostic cutoff value from point X (sensitivity , specificity ) to point Y (sensitivity , specificity ).
Assuming the patient population and disease prevalence remain identical, which of the following statements most accurately describes the expected statistical impact of this cutoff adjustment?
- AThe positive predictive value will increase, and the negative likelihood ratio will decrease.
- BThe false discovery rate will decrease, and the area under the receiver operating characteristic curve will remain unchanged.
- The negative predictive value will increase, and the area under the receiver operating characteristic curve will remain unchanged.Answer
- DThe negative predictive value will increase, and the positive predictive value will remain unchanged.
- EBoth the negative predictive value and the area under the receiver operating characteristic curve will increase.